UGN-102 shows better results after 12 months of treatment for low-grade intermediate-risk NMIBC
UGN-102 shows better results after 12 months of treatment for low-grade intermediate-risk NMIBC
CaboNivo shows sustained long-term benefits for survival and tumour progression as a 1L treatment of aRCC
HSD3B1 inheritance reduces OS in high-risk nmPC patients on ADT enzalutamide, abiraterone acetate plus prednisolone
Enfortumab vedotin in combination with pembrolizumab shows improved survival rates in la/mUC
SIOG 2024: Updates in radiation oncology
SIOG 2024: Updates in medical oncology
Patterns and correlates of multiple tobacco product use among people with HIV in India
Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations
Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal compared to nivolumab monotherapy
Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia
Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T ce may reduce toxicity in older lymphoma patients
Robotic surgery for older patients with colorectal cancer shows positive outcomes